This article provides an encompassing review of the current pipeline of putative and
developed treatments for tuberculosis, including multidrug-resistant strains. The review has …

Background: Identification of therapies to prevent severe COVID-19 remains a priority. We
sought to determine whether hydroxychloroquine treatment for outpatients with SARS-CoV-2 …

Isoniazid resistant Mycobacterium tuberculosis (Hr-TB) is the most frequently encountered TB
resistance phenotype in North America but limited data exist on the effectiveness of current …

Escherichia coli is frequently isolated from the respiratory secretions of cystic fibrosis (CF)
patients yet is not considered a classical CF pathogen. Accordingly, little is known about the …

… Correspondence and requests for reprints should be addressed to Brett D. Edwards, MD,
Division of Infectious Diseases, University of Calgary, 3500 26 Avenue Northeast, Calgary, AB, …

Nitrofurantoin is recommended as first-line therapy for uncomplicated cystitis owing to its
comparable efficacy to cotrimoxazole, minimal resistance, and reduced risk of inducing …

Background: The treatment of tuberculosis (TB) is known to cause liver injury, however, there
is limited data to guide optimal treatment for patients with chronic liver disease. Methods: …

We describe three cases of orthopaedic contamination caused by Ralstonia pickettii grown
from prosthetic joint and implant material cultures following sonication in the microbiology …

Treatment of rifampin-monoresistant/multidrug-resistant Tuberculosis (RR/MDR-TB) requires
long treatment courses, complicated by frequent adverse events and low success rates. …

Mycobacterium elephantis was first described when isolated from an elephant that succumbed
to lung abscess. However, despite this namesake, it is not associated with animals and …